supplementary files for study entitled "Systematic review and meta-analysis of the efficacy and risk of adverse events of dupilumab in the treatment of prurigo nodularis"

Name: supplementary files for study entitled "Systematic review and meta-analysis of the efficacy and risk of adverse events of dupilumab in the treatment of prurigo nodularis"
Creator: Hicham Titou
Published: 2025-01-06T14:32:46.006Z
Keywords: Dermatology

Titou, Hicham; Elkhachine, younes; El Benaye, jalal

doi:10.17632/tnd5kkzhxt.1

supplementary files for study entitled "Systematic review and meta-analysis of the efficacy and risk of adverse events of dupilumab in the treatment of prurigo nodularis"

Published: 6 January 2025| Version 1 | DOI: 10.17632/tnd5kkzhxt.1

Contributors:

Hicham Titou,

,

Description

• Real-world data reveal that dupilumab therapy for prurigo nodularis is effective and well tolerated in the short term, but ophthalmic adverse events frequently occur. • Clinical trials demonstrated that dupilumab is effective and safe for the treatment of prurigo nodularis in adults.

supplementary files for study entitled "Systematic review and meta-analysis of the efficacy and risk of adverse events of dupilumab in the treatment of prurigo nodularis"

Description

Files

Categories

Licence